Antiviral Treatment During Pregnancy Reduces Mother-to-Child Transmission of Hepatitis B

Daily treatment with the antiviral drug tenofovir during the third trimester of pregnancy reduced the mother-to-child transmission rate of hepatitis B (HBV) from 18% to 5%, according to the findings of a clinical trial led by researchers from NYU Langone Medical Center and published in the New England Journal of Medicine.

 

Adolescents with HIV need to be rapidly linked to specialist care to have best chances of sustaining engagement with HIV services

Adolescents newly diagnosed with HIV need to be rapidly incorporated into HIV care networks to have the best chances of remaining in care in the long term, research from the United States published in the June 1st edition of the Journal of Acquired Immune Deficiency Syndromes shows.

US funding for key populations ‘small win’ from controversial UN meeting

The US President’s Emergency Plan for AIDS Relief (PEPFAR) has created an investment fund of US $100 million earmarked for key populations most affected by HIV, including men who have sex with men (MSM), sex workers, people who use drugs, prisoners and transgender people.

Thailand first Asian country to eliminate mother-to-child transmission of HIV

Thailand has become the first country in Asia to eliminate mother-to-child transmission of HIV, meaning the rate of transmission has fallen below 2%.

2 million more on HIV treatment in 2015

At least two million more people were accessing HIV treatment globally in 2015 than a year earlier, according to new data from UNAIDS. In total 17 million people were on HIV treatment, up by a third since 2013.

Login Form

Mailbox

You are not logged in.

Breaking The Walls

Poster Ranaa ar web


Media

3rd Inter-regional Consultation on HIV‬ - related Services and Rights

25-27 November 2015, Harare - Zimbabwe.

12278726 10153776200664233 2484133095798495308 n

 

Regional Dialogue Focus Meeting Assembly

8 - 11 December 2015, Beirut - Lebanon

‪#‎MENADialogue2015

aaaaaapic.jpg

 


You are here: